Subcutaneously Delivered Nano-Insulin Drug as Label Free Nanotheranostic
Abstract In this study, it has aimed to understand the relationship between purified insulin and insulin receptor, also nanoinsulin and insulin receptors. The insulin receptor has separated from rat liver using a cryogel column material that is photosensitively insulin cross-linked in the Fast Protein Liquid Chromatography (FPLC) system based on the affinity between insulin and insulin receptor. In the second step, an isolated insulin receptor has used to synthesize insulin receptor cross-linked cryogels for purifying insulin from rats. Subcutaneously delivered nano-insulin drug has prepared from the purified insulin using AmiNoAcid (monomer) Decorated and Light Underpinning Conjugation Approach (ANADOLUCA) method. Lastly, Reflectometric Interference Spectroscopy (RIfS) study has performed to understand the interaction between purified insulin receptor and purified insulin, commercial insulin analog, and nano insulin. These studies have demonstrated that nano-insulin drugs can be effectively used as a theranostic platform to monitor affinity and blocking interactions of nanoprotein drug and its receptor.